Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-553 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553 |
filingDate |
1977-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4798fb432f7b342142431f200f88773c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54af6e8db59d6e04a3ed0c29582622ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0751b17bbc91739766362931df4a1f15 |
publicationDate |
1982-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CH-630907-A5 |
titleOfInvention |
Process for preparing derivatives of 1-carbamoyluracil. |
abstract |
Compounds of the formula: <IMAGE> are prepared by reacting a uracil, which is optionally substituted in the 5 position by halogen, methyl or trifluoromethyl, with an amine HNRR' and phosgene. R denotes hydrogen or a hydrocarbon radical and R' denotes a hydrocarbon radical, or R and R' together represent a divalent hydrocarbon radical. Some of the products of the process are novel compounds; they are distinguished by having anti-tumour activity and can be administered per os. As compared with the previously known syntheses, the process has the advantage of consisting of one single and simple reaction step. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240352-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2539412-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240352-A3 |
priorityDate |
1976-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |